Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Argenx Se Ads
(NQ:
ARGX
)
340.53
USD
+9.85 (+2.98%)
Official Closing Price
Updated: 4:57 PM EST, Mar 1, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
117,200
Open
335.66
Bid (Size)
332.30 (5)
Ask (Size)
341.00 (3)
Prev. Close
330.68
Today's Range
334.07 - 342.85
52wk Range
103.75 - 382.15
Shares Outstanding
32,403,133
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
argenx Announces FDA Acceptance of BLA Filing for Efgartigimod for the Treatment of Generalized Myasthenia Gravis
Today 2:00 EST
From
GlobeNewswire News Releases
argenx to Report Full Year 2020 Financial Results and Fourth Quarter Business Update on March 4, 2021
February 25, 2021
From
GlobeNewswire News Releases
Performance
YTD
+14.64%
+14.64%
1 Month
+7.29%
+7.29%
3 Month
+18.73%
+18.73%
6 Month
+47.24%
+47.24%
1 Year
+130.10%
+130.10%
More News
Read More
argenx announces closing of global offering
February 05, 2021
From
GlobeNewswire News Releases
argenx announces full exercise of underwriters’ option to purchase additional ADSs
February 04, 2021
From
GlobeNewswire News Releases
argenx raises $1.0 billion in gross proceeds in a global offering
February 02, 2021
From
GlobeNewswire News Releases
argenx Issues Statement Concerning Efgartigimod
February 02, 2021
From
GlobeNewswire News Releases
argenx announces launch of proposed global offering
February 01, 2021
From
GlobeNewswire News Releases
argenx Announces “GO” Decision in ADHERE Trial of Efgartigimod in Chronic Inflammatory Demyelinating Polyneuropathy Following Interim Analysis
February 01, 2021
From
GlobeNewswire News Releases
12 Health Care Stocks Moving In Monday's Pre-Market Session
February 08, 2021
Tags
Markets
PHAR
Top Gainers
From
Benzinga
The Daily Biotech Pulse: European Regulatory Nod For Xeris, Amicus Falls On Data, 4 IPOs, FDA Decision For Mallinckrodt's StrataGraft Delayed
February 12, 2021
Tags
FDMT
FGEN
ONVO
From
Benzinga
The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs
February 10, 2021
Tags
JAZZ
GHSI
VERU
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.